Skip to Content

93 1026 (Nefazodone Hydrochloride 250 mg)

Pill with imprint 93 1026 is White, Elliptical / Oval and has been identified as Nefazodone Hydrochloride 250 mg. It is supplied by Teva Pharmaceuticals USA.

Nefazodone is used in the treatment of major depressive disorder; depression and belongs to the drug class phenylpiperazine antidepressants. Risk cannot be ruled out during pregnancy. Nefazodone 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 93 1026

Nefazodone hydrochloride 250 mg 93 1026
Nefazodone hydrochloride 250 mg 93 1026 Front
Nefazodone hydrochloride 250 mg 93 1026 Back
Nefazodone hydrochloride 250 mg 93 1026 Front
Nefazodone hydrochloride 250 mg 93 1026 Back
Nefazodone hydrochloride 250 mg 93 1026
Nefazodone hydrochloride 250 mg 93 1026

Nefazodone Hydrochloride

Imprint
93 1026
Strength
250 mg
Color
White
Size
16.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Phenylpiperazine antidepressants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA
Inactive Ingredients
silicon dioxide, magnesium stearate, microcrystalline cellulose, sodium starch glycolate type A potato, povidone k30

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00093-1026 Teva Pharmaceuticals USA, Inc.
42291-0627 AvKare, Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.